Protective effect of inositol hexaphosphate against UVB damage in HaCaT cells and skin carcinogenesis in SKH1 hairless mice

Comparative Medicine

Volumn 61, Issue 1, 2011, Pages 39-44

  Williams, Kendra A ^a   Kolappaswamy, Krishnan ^a   DeTolla, Louis J ^a   Vucenik, Ivana ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; PHYTIC ACID;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; KERATINOCYTE; MOUSE; NONHUMAN; RADIATION DOSE; RADIATION EXPOSURE; RADIATION INJURY; SKIN CARCINOGENESIS; ULTRAVIOLET B RADIATION;

ANIMALS; APOPTOSIS; CELL CYCLE; CELL LINE; FEMALE; HUMANS; KERATINOCYTES; MICE; PHYTIC ACID; SKIN NEOPLASMS; ULTRAVIOLET RAYS;

EID: 80054014668     PISSN: 15320820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Abu-Yousif AO, Smith KA, Getsios S, Green KJ, Van Dross RT, Pelling JC. 2008. Enhancement of UVB-induced apoptosis by apigenin in human keratinocytes and organotypic keratinocyte cultures. Cancer Res 68:3057-3065. (Pubitemid 351556308)
2. Assefa Z, Van Laethem A, Garmyn M, Agostinis P. 2005. Ultraviolet radiation-induced apoptosis in keratinocytes: on the role of cytosolic factors. Biochim Biophys Acta 1755:90-106. (Pubitemid 40982560)
3. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE. 1988. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 106:761-771. (Pubitemid 18089976)
4. Bowden GT. 2004. Prevention of nonmelanoma skin cancer by targeting UVB light signalling. Nat Rev Cancer 4:23-35. (Pubitemid 38082151)
5. Chaturvedi V, Qin JZ, Denning MF, Choubey D, Diaz MO, Nickoloff BJ. 2001. Abnormal NF?B signaling pathway with enhanced susceptibility to apoptosis in immortalized keratinocytes. J Dermatol Sci 26:67-78. (Pubitemid 32372657)
6. Claerhout S, Decraene D, Van Laethem A, Van Kelst S, Agostinis P, Garmyn M. 2007. AKT delays the early-activated apoptotic pathway in UVB-irradiated keratinocytes via BAD translocation. J Invest Dermatol 127:429-438. (Pubitemid 46106923)
7. Claerhout S, Van Laethem A, Agostinis P, Garmyn M. 2006. Pathways involved in sunburn cell formation: deregulation in skin cancer. Photochem Photobiol Sci 5:199-207. 8. de Gruijl FR. 2002. Photocarcinogenesis: UVA vs UVB radiation. Skin Pharmacol Appl Skin Physiol 15:316-320.
8. de Gruijl FR, Forbes PD. 1995. UV-induced skin cancer in a hairless mouse model. Bioessays 17:651-660.
9. de Gruijl FR, van Kranen HJ, Mullenders LH. 2001. UV-induced DNA damage, repair, mutations, and oncogenic pathways in skin cancer. J Photochem Photobiol B 63:19-27. (Pubitemid 33040719)
10. Dhanalakshmi S, Mallikarjuna GU, Singh RP, Agarwal R. 2004. Dual efficacy of silibinin in protecting or enhancing UVB radiationcaused apoptosis in HaCaT human immortalized keratinocytes. Carcinogenesis 25:99-106. (Pubitemid 38128622)
11. Dhanalakshmi S, Mallikarjuna GU, Singh RP, Agarwal R. 2004. Silibinin prevents UV radiation-caused skin damages in SKH1 hairless mice via a decrease in thymine dimer positive cells and an upregulation of p53-p21/Cip1 in epidermis. Carcinogenesis 25:1459-1465. (Pubitemid 39162712)
12. Diepgen TL, Mahler V. 2002. The epidemiology of skin cancer. Br J Dermatol 146 Suppl61:1-6.
13. El-Mahdy MA, Zhu Q, Wang QE, Wani G, Patnaik S, Zhao Q, Arafa el-S, Barakat B, Mir SN, Wani AA. 2008. Naringenin protects HaCaT human keratinocytes against UVB-induced apoptosis and enhances the removal of cyclobutane pyrimidine dimers from the genome. Photochem Photobiol 84:307-316. (Pubitemid 351421382)
14. El-Sherbiny YM, Cox MC, Ismail ZA, Shamsuddin AM, Vucenik I. 2001. G0-G1 arrest and S phase inhibition of human cancer cell lines by inositol hexaphosphate (IP6). Anticancer Res 21:2393-2403. (Pubitemid 33054401)
15. Farkas B, Magyarlaki M, Csete B, Nemeth J, Rabloczky G, Bernath S, Literati Nagy P, Sumegi B. 2002. Reduction of acute photodamage in skin by topical application of a novel PARP inhibitor. Biochem Pharmacol 63:921-932. (Pubitemid 34243005)
16. Ferry S, Matsuda M, Yoshida H, Hirata M. 2002. Inositol hexakisphosphate blocks tumor cell growth by activating apoptotic machinery as well as by inhibiting the Akt/NFκB- mediated cell survival pathway. Carcinogenesis 23:2031-2041. (Pubitemid 36109120)
17. Fisher GJ, Datta SC, Talwar HS, Wang ZQ, Varani J, Kang S, Voorhees JJ. 1996. Molecular basis of sun-induced premature skin ageing and retinoid antagonism. Nature 379:335-339. (Pubitemid 26033074)
18. Garssen J, Vandebriel RJ, De Gruijl FR, Wolvers DA, Van Dijk M, Fluitman A, Van Loveren H. 1999. UVB exposure-induced systemic modulation of Th1- and Th2-mediated immune responses. Immunology 97:506-514. (Pubitemid 29314649)
19. Gilchrest BA. 1996. A review of skin aging and its medical therapy. Br J Dermatol 135:867-875. (Pubitemid 26397913)
20. Graf E, Eaton JW. 1990. Antioxidant functions of phytic acid. Free Radic Biol Med 8:61-69.
21. Grases F, Isern B, Prieto RM. 2005. Study of the absorption of myo-inositol hexakisphosphate (InsP6) through the skin. Biol Pharm Bull 28:764-767. (Pubitemid 40879956)
22. Grases F, Prieto RM, Simonet BM, March JG. 2000. Phytate prevents tissue calcifications in female rats. Biofactors 11:171-177. (Pubitemid 30365965)
23. Gupta KP, Singh J, Bharathi R. 2003. Suppression of DMBA-induced mouse skin tumor development by inositol hexaphosphate and its mode of action. Nutr Cancer 46:66-72. (Pubitemid 37163293)
24. Hanakahi LA, Bartlet-Jones M, Chappell C, Pappin D, West SC. 2000. Binding of inositol phosphate to DNA-PK and stimulation of double-strand break repair. Cell 102:721-729.
25. Hawkins PT, Poyner DR, Jackson TR, Letcher AJ, Lander DA, Irvine RA. 1993. Inhibition of iron-catalysed hydroxyl radical formation by inositol polyphosphates: a possible physiological function for myo-inositol hexaphosphate. Biochem J 294:929-934. (Pubitemid 23286588)
26. Hwang H, Chen T, Nines RG, Shin HC, Stoner GD. 2006. Photochemoprevention of UVB-induced skin carcinogenesis in SKH1 mice by brown algae polyphenols. Int J Cancer 119:2742-2749. (Pubitemid 44846224)
27. Institute for Laboratory Animal Research. 1996. Guide for the care and use of laboratory animals. Washington (DC): National Academies Press.
28. Ishikawa T, Nakatsuru Y, Zarkovic M, Shamsuddin AM. 1999. Inhibition of skin cancer by IP6 in vivo: initiation-promotion model. Anticancer Res 19:3749-3752.
29. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. 2009. Cancer statistics. CA Cancer J Clin 59:225-249.
30. Kolappaswamy K, Williams KA, Benazzi C, Sarli G, McLeod CG Jr, Vucenik I, DeTolla LJ. 2009. Effect of inositol hexaphosphate on the development of UVB-induced skin tumors in SKH1 hairless mice. Comp Med 59:147-152.
31. Kulms D, Schwartz T. 2000. Molecular mechanisms of UV-induced apoptosis. Photodermatol Photoimmunol Photomed 16:195-201.
32. Latonen L, Taya Y, Laiho M. 2001. UV radiation induces dose-dependent regulation of p53 response and modulates p53-HDM2 interaction in human fibroblasts. Oncogene 20:6784-6793. (Pubitemid 33020607)
33. Liu S, Mizu H, Yamauchi H. 2007. Molecular response to phototoxic stress of UVB-irradiated ketoprofen through arresting cell cycle in G2-M phase and inducing apoptosis. Biochem Biophys Res Commun 364:650-655. (Pubitemid 350026512)
34. Magal SS, Jackman A, Pei XF, Schlegel R, Sherman L. 1998. Induction of apoptosis in human keratinocytes containing mutated p53 alleles and its inhibition by both the E6 and E7 oncoproteins. Int J Cancer 75:96-104. (Pubitemid 28113983)
35. Matsumura Y, Ananthaswamy HN. 2004. Toxic effects of UV radiation on the skin. Toxicol Appl Pharmacol 195:298-308.
36. Midorikawa K, Murata M, Oikawa S, Hiraku Y, Kawanishi S. 2001. Protective effect of phytic acid on oxidative DNA damage with reference to cancer chemoprevention. Biochem Biophys Res Commun 288:552-557. (Pubitemid 33030065)
37. Petrocelli T, Poon R, Drucker DJ, Slingerland JM, Rosen CF. 1996. UVB radiation induces p21Cip1/WAF1 and mediates G1 and S phase checkpoints. Oncogene 12:1387-1396.
38. Reagan-Shaw S, Afaq F, Aziz MH, Ahmad N. 2004. Modulations of critical cell cycle regulatory events during chemoprevention of UVB-mediated responses by resveratrol in SKH1 hairless mouse skin. Oncogene 23:5151-5160. (Pubitemid 38980348)
39. Rizvi I, Ng A, Riggs D, Jackson B, Cunningham C, McFadden D. 2006. Inositol hexaphosphate (IP6) inhibits cellular proliferation and VEGF production in melanoma. J Surg Res 130:192.
40. Rizvi I, Riggs DR, Jackson BJ, Ng A, Cunningham C, McFadden DW. 2006. Inositol hexaphosphate (IP6) inhibits cellular proliferation in melanoma. J Surg Res 133:3-6.
41. Shamsuddin AM, Vucenik I. 1999. Mammary tumor inhibition by IP6: a review. Anticancer Res 19:3671-3674.
42. Shamsuddin AM, Vucenik I, Cole KE. 1997. IP6: a novel anticancer agent. Life Sci 61:343-354.
43. Shamsuddin AM, Yang GY, Vucenik I. 1996. Novel anticancer functions of IP6: growth inhibition and differentiation of human mammary cancer cell lines in vitro. Anticancer Res 16:3287-3292. (Pubitemid 27085072)
44. Singh J, Gupta KP. 2008. Inositol hexaphosphate induces apoptosis by coordinative modulation of p53, Bcl2, and sequential activation of caspases in 7,12 dimethylbenz[a]anthracene-exposed mouse epidermis. J Environ Pathol Toxicol Oncol 27:209-217.
45. Singh RP, Agarwal C, Agarwal R. 2003. Inositol hexaphosphate inhibits growth and induces G1 arrest and apoptotic death of prostate carcinoma DU145 cells: modulation of CDKI-CDK-cyclin and pRb-related protein-E2F complexes. Carcinogenesis 24:555-563. (Pubitemid 36432653)
46. Sluss HK, Jones SN. 2003. Analysing p53 tumour suppressor functions in mice. Expert Opin Ther Targets 7:89-99. (Pubitemid 36204591)
47. Vucenik I, Passaniti A, Vitolo MI, Tantivejkul K, Eggleton P, Shamsuddin AM. 2004. Antiangiogenic activity of inositol hexaphosphate (IP6). Carcinogenesis 25:2115-2123. (Pubitemid 39534848)
48. Vucenik I, Shamsuddin AM. 2003. Cancer inhibition by inositol hexaphosphate (IP6) and inositol: from laboratory to clinic. J Nutr 133:3778S-3784S. (Pubitemid 37392600)
49. Vucenik I, Shamsuddin AM. 2006. Protection against cancer by dietary IP6 and inositol. Nutr Cancer 55:109-125. (Pubitemid 44719624)
50. Vucenik I, Tomazic VJ, Fabian D, Shamsuddin AM. 1992. Antitumor activity of phytic acid (inositol hexaphosphate) in murine transplanted and metastatic fibrosarcoma: a pilot study. Cancer Lett 65:9-13.
51. Vucenik I, Yang GY, Shamsuddin AM. 1997. Comparison of pure inositol hexaphosphate and high-bran diet in the prevention of DMBA-induced rat mammary carcinogenesis. Nutr Cancer 28:7-13. (Pubitemid 27287622)
52. Wang CB, Huang MQ, Tao GL, Yu GY, Han ZW, Yang ZH, Wang YJ. 2004. Polypeptide from Chlamys farreri protects HaCaT cells from UVB-induced apoptosis. Chem Biol Interact 147:119-127. (Pubitemid 38315021)
53. Yarosh DB, Boumakis S, Brown AB, Canning MT, Galvin JW, Both DM, Kraus E, O'Connor A, Brown DA. 2002. Measurement of UVB-induced DNA damage and its consequences in models of immunosuppression. Methods 28:55-62.